Anti-aging research

This summary highlights what we currently know of telomeres and the telomerase enzyme as potential anti-aging targets.

Rapamycin is used as an immunosuppressant, however, it has recently gained significant attention in the anti-aging research communities.

A recent study explores the potential of reversing age-related biological changes by targeting the insulin/IGF-1 signaling pathway

A recently published research review explores ferroptosis and its significant implications for aging and age-related diseases.

Research suggests that an Astragalus-based supplement may help lengthen telomeres, and thereby reduce cellular age-related decline.

Recent research has identified HAPLN1 (hyaluronan and proteoglycan link protein 1) as a promising factor for rejuvenating aged skin.

Research shows that cellular senescence can play a positive role in tissue repair, particularly in the meniscus of the knee.

A research review suggests that combining mTOR inhibitors and SGLT-2 inhibitors could provide benefits in slowing down the aging process.

Research suggests that targeting multiple aspects of aging through combination therapies could be more effective than single interventions.

Research shows how Amyloid Beta (Aβ) may accelerate aging via protein insolubility, and identifies Urolithin A as a potential solution.